You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Enento Q2'24: Solid performance in a challenging environment
Enento's development in Finland, Norway and Denmark continued in a positive direction while consumer credit information sector continued to face a challenging operating environment in Q2. CEO Jeanette Jäger and CFO Elina Stråhlman comments on the past quarter in this interview.
Content:
00:00 Intro
00:15 Enento Q2
01:52 Costs transferred to H2
03:51 Positive credit register
04:47 Discussion about over-indebtedness
05:40 H2 expectations
06:10 Sweden markets
07:28 Mergers and acquisitions
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Vis alle videoer